1. Home
  2. HUBC vs CARA Comparison

HUBC vs CARA Comparison

Compare HUBC & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • CARA
  • Stock Information
  • Founded
  • HUBC 2017
  • CARA 2004
  • Country
  • HUBC Israel
  • CARA United States
  • Employees
  • HUBC N/A
  • CARA N/A
  • Industry
  • HUBC
  • CARA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • CARA Health Care
  • Exchange
  • HUBC Nasdaq
  • CARA Nasdaq
  • Market Cap
  • HUBC 15.2M
  • CARA 16.7M
  • IPO Year
  • HUBC N/A
  • CARA 2014
  • Fundamental
  • Price
  • HUBC $0.81
  • CARA $4.65
  • Analyst Decision
  • HUBC
  • CARA Hold
  • Analyst Count
  • HUBC 0
  • CARA 3
  • Target Price
  • HUBC N/A
  • CARA $12.00
  • AVG Volume (30 Days)
  • HUBC 3.8M
  • CARA 331.3K
  • Earning Date
  • HUBC 12-13-2024
  • CARA 03-03-2025
  • Dividend Yield
  • HUBC N/A
  • CARA N/A
  • EPS Growth
  • HUBC N/A
  • CARA N/A
  • EPS
  • HUBC N/A
  • CARA N/A
  • Revenue
  • HUBC $33,357,000.00
  • CARA $8,686,000.00
  • Revenue This Year
  • HUBC N/A
  • CARA N/A
  • Revenue Next Year
  • HUBC N/A
  • CARA N/A
  • P/E Ratio
  • HUBC N/A
  • CARA N/A
  • Revenue Growth
  • HUBC N/A
  • CARA N/A
  • 52 Week Low
  • HUBC $0.37
  • CARA $2.71
  • 52 Week High
  • HUBC $2.17
  • CARA $13.80
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 58.71
  • CARA 52.14
  • Support Level
  • HUBC $0.51
  • CARA $4.32
  • Resistance Level
  • HUBC $0.92
  • CARA $4.92
  • Average True Range (ATR)
  • HUBC 0.20
  • CARA 0.66
  • MACD
  • HUBC 0.00
  • CARA -0.10
  • Stochastic Oscillator
  • HUBC 44.09
  • CARA 28.75

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Share on Social Networks: